contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


optomed-oyj-decisions-of-the-organization-meeting-of-optomeds-board-of-directors-1

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

There is nothing wrong with LinkedIn or other social media posts. Quite the opposite. They provide good background information both on a general level and more specific, important info. For example, that Gitex Africa event post you shared contained significant information for shareholders. We learned about the BP (Big Pharma) partner and also the algorithm that will be utilized. That algorithm for chronic kidney disease was also yet another confirmation that fundus images can be used to screen for much more than just retinopathy. In fact, a screening for dementia/Alzheimer’s was already introduced in China, which is the result of international cooperation and not just a Chinese thing. That also uses fundus images. So, over time, a good bundle of different algorithms for various diseases will be added to the Lumo camera. AstraZeneca, which was revealed at the Gitex Africa event, is not necessarily the only BP company with which a partnership agreement will be made. Roche, which has been featured, and others are also entirely possible. AstraZeneca is an excellent reference for Optomed and the Lumo camera. One could certainly consider that joint presentation at the Gitex event as a semi-official partnership announcement.

Something that wasn’t emphasized: a portable device intended for AI-diagnostics.

If the FDA and CE-approved Remidio handheld camera were “bad,” Bill Gates wouldn’t be holding it. It can be as bulky as it wants as long as it does its job and is accepted by the market.

What a clumsy-looking hunk of junk. And it doesn’t have FDA clearance for AI scans. Juho mentioned at the annual general meeting that Lumo might potentially have a lighter approval process since Aurora already has FDA clearance, so the number of required images and studies could remain lower, but this isn’t certain, so let’s not take it as a promise. Bill can give our board a call and inquire about a 10% price for a stake

Interesting that Bill Gates is interested in this market?

LinkedIn              The Remidio retinal scanner shows how even the smallest innovations can have...    The Remidio retinal scanner shows how even the smallest innovations can have an outsized impact on maternal care. It’s a portable, battery-operated camera that captures high-resolution images of the retina in seconds. By flagging early signs of...                             Here, Bill Gates is introducing a competitor to Optomed

LinkedIn              #optomedlumo #optomedaurora #portable #retinal #screening #ai #capturinghealth...    World Congress of Diabetes Technology & Therapeutics 2026 - Mumbai India  Taking the next steps within our strategy in India and approaching diabetes communities and experts with #OptomedLumo and already in use #OptomedAurora.  #Portable #retinal...                             Plenty of interest in India

Optomed

Optomed Plc Stock Exchange Release 8 May 2026 at 20.00 , HelsinkiDecisions of the Organization Meeting of Optomed's Board of DirectorsAt its meeting held after the Annual General Meeting, the...

Optomed Plc&nbsp;Stock Exchange Release&nbsp;8 May 2026 at 20.00 , HelsinkiDecisions of the Organization Meeting of Optomed's Board of DirectorsAt its meeting held after the Annual General Meeting, the Board of Directors elected from among its members Petri Salonen as its Chair. The committee members were elected as follows:&nbsp;Audit Committee:·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reijo Tauriainen (Chair)·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kristiina Leppänen·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Catherine Calarco·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sameer Badlani&nbsp;Remuneration Committee:·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ty Lee (Chair)·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seppo Mäkinen·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Leana Wen Optomed Plc Further enquiriesPetri Salonen, Chairman, Optomed Plc, <a href="mailto:petri.salonen@optomed.com">petri.salonen@optomed.com</a> &nbsp;&nbsp;&nbsp;Optomed in Brief&nbsp;Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases, such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye screening devices and software solutions related R&amp;D in Finland and sales through different channels in over 60 countries.<a href="http://www.optomed.com">www.optomed.com</a>&nbsp;<div></div>